openPR Logo
Press release

Digital Diabetes Management Market Key Players Analysis - Medteronic (Ireland), B.Melsungen AG (Germany), Dexcom, Inc. (US), Abbott Laboratories (US), F. Hoffmann-La Roche (Switzerland).

08-26-2025 09:19 AM CET | Health & Medicine

Press release from: Insightace Analytic Pvt Ltd.

Digital Diabetes Management Market

Digital Diabetes Management Market

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Digital Diabetes Management Market - (By Devices (Smart Glucose Meters, Continuous Glucose Monitoring Systems, And Smart Insulin Pens, Smart Insulin Pumps/ Closed-Loop Pumps & Smart Insulin Patches), Application (Diabetes & Blood Glucose Tracking Apps, Obesity & Diet Management Apps), Data Management Software & Platforms And Services), By Device Type (Handheld And Wearable Devices), By End-User(Self/Home Healthcare, Hospitals & Speciality Diabetes Clinics And Academic & Research Institutes))), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."

"Digital Diabetes Management Market" in terms of revenue was estimated to be worth USD 20.4 Billion in 2024 and is poised to reach USD 74.6 Billion by the year 2034, growing at a CAGR of 13.9% from 2025 to 2034 according to a new report by InsightAce Analytic.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1487

Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the digital diabetes management market are:
• Technological advancements
• Combining therapeutic and monitoring capabilities
• Artificial intelligence and data analytics integration

The following are the primary obstacles to the digital diabetes management market 's expansion:
• High cost
• Lack of awareness
• privacy issues about data

Future expansion opportunities for the digital diabetes management market include:
• Increasingly popular usage of interconnected gadgets
• Increase in the prevalence of diabetes
• Growing population

Market Analysis:
Digital diabetes management encompasses a range of advanced technologies aimed at enhancing the monitoring and treatment of diabetes. Key solutions include smart insulin pens, continuous glucose sensors, connected glucose meters, closed-loop insulin delivery systems, insulin patches, and software-driven platforms and applications. Among these, smart insulin pens offer significant advantages by improving dosing precision and supporting better patient adherence.

Ongoing technological innovations have led to increasingly sophisticated and user-friendly solutions, fostering wider adoption across the healthcare ecosystem. Furthermore, the widespread use of smartphones and the growing prevalence of internet-enabled health monitoring applications are serving as important catalysts for the expansion of the digital diabetes management market.

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-01

List of Prominent Players in the Digital Diabetes Management Market:
• Medtronic
• B. Braun Melsungen AG
• Dexcom, Inc
• Abbott Laboratories
• F. Hoffmann-La Roche
• Insulet Corporation
• Tandem Diabetes Care
• Ascensia Diabetes Care Holdings AG
• LifeScan, Inc
• Tidepool
• AgaMatrix
• Glooko, Inc
• DarioHealth Corporation
• One Drop
• Dottli
• Ypsomed Holding AG
• ARKRAY
• ACON Laboratories, Inc
• Care Innovations, LLC
• Health2Sync
• Emperra GmbH E-Health Technologies
• Azumio
• Decide Clinical Software GmbH
• Pendiq GmbH
• BeatO

Recent Developments:
• In January 2024, Tandem Diabetes Care, Inc. announced that their t: slim X2 insulin pump with Control-IQ technology is the first AID system to connect with Abbott's latest continuous glucose monitoring (CGM) device, the FreeStyle Libre 2 Plus.
• In November 2023, Ascensia Diabetes Care Poland was recognized as a Great Place to Work by the esteemed organization. Ascensia Diabetes Care is a worldwide leader in diabetes care, known for its CONTOUR Blood Glucose Monitoring (BGM) System portfolio and its exclusive distribution of Eversense Continuous Glucose Monitoring (CGM) Systems.
• In October 2023, Insulet recently made headlines when it announced that the FDA had cleared its Omnipod 5 App for iPhone under the 510(k) program. This makes Insulet the only company in the world to offer a tubeless automated insulin delivery (AID) system that can be fully controlled from an Android or iOS smartphone.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1487

Digital Diabetes Management Market Dynamics
Market Drivers: Technological Advancements
The global digital diabetes management market is expected to experience significant growth, driven primarily by ongoing innovations in smart insulin delivery technologies. Advanced solutions, such as smart insulin pens with iSenz adapters, facilitate precise tracking of insulin levels and improved injection accuracy, thereby enhancing patient adherence and comfort.

Integration with Easylog adapters enables seamless connectivity to internet-enabled platforms, supporting real-time monitoring and data sharing. Furthermore, the widespread use of smartphones and growing adoption of digital health tracking applications are accelerating market expansion, as consumers increasingly rely on digital tools for proactive diabetes management.

Challenges: High Costs
Despite these advancements, the market faces several challenges. The high cost of digital diabetes management solutions limits accessibility, particularly in developing and emerging economies. Additionally, effective utilization of these technologies requires specialized training for healthcare professionals to accurately interpret glucose data, adding operational complexity. Concerns regarding data privacy, coupled with limited awareness of digital diabetes tools in underdeveloped regions, further constrain widespread adoption.

Regional Trends
North America is anticipated to maintain its leadership position in the digital diabetes management market, with the highest projected compound annual growth rate (CAGR) over the forecast period. This dominance is supported by strong demand for digital healthcare solutions, a high prevalence of chronic diseases, and a well-established healthcare infrastructure. Additional growth drivers include a mature supply chain, rapid adoption of advanced technologies, and favorable reimbursement policies that facilitate the integration of digital diabetes management systems across the region.

Segmentation of Digital Diabetes Management Market-
By Product & Service
• Devices
o Smart Glucose Meters
o Continuous Glucose Monitoring (CGM) Systems
o Smart Insulin Pens
o Smart Insulin Pumps/Closed-loop Pumps & Smart Insulin Patches
• Application
o Diabetes & Blood Glucose Tracking Apps
o Obesity & Diet Management Apps
• Data Management Software & Platforms
• Services
By Device Type
• Handheld Devices
• Wearable Devices
By End User
• Self/Home Healthcare
• Hospitals & Specialty Diabetes Clinics
• Academic & Research Institutes
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

Read Overview Report- https://www.insightaceanalytic.com/report/global-digital-diabetes-management-market/1487

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Digital Diabetes Management Market Key Players Analysis - Medteronic (Ireland), B.Melsungen AG (Germany), Dexcom, Inc. (US), Abbott Laboratories (US), F. Hoffmann-La Roche (Switzerland). here

News-ID: 4159421 • Views:

More Releases from Insightace Analytic Pvt Ltd.

Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market to Grow at 5.3% CAGR Amid Rising Awareness of PCOS and PMS
Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market to Grow at 5 …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market- (By Product Type (Combined Nutritional Supplements, Single Nutritional Supplements), By Type Indication (Perimenopause, PMS), By Formulation (Capsules/Tablets, Powder, Softgels, Other), By Sales Channel (Pharmacies/Drug Stores, Online Sales Channel, Direct Sales Channel, Others)), By Region, Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the latest research
Cell and Gene Therapy CRO Market Forecast Shows Robust Growth Across North America, Europe, and Asia-Pacific
Cell and Gene Therapy CRO Market Forecast Shows Robust Growth Across North Ameri …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Cell and Gene Therapy CRO Market- (By Type of Cell Therapy (CAR-NK, CAR-T, TCR-T, and Others), By Type of Genetic Modification (Ex vivo and In vivo), By Stage of Development (Discovery, Preclinical, and Clinical)), By Therapeutic Area, By End-user, By Region, Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the latest research by
Bioseparation Systems Market Top Companies Study - GE Healthcare Life Sciences, Pall Corporation, 3M Company, Waters Corporation.
Bioseparation Systems Market Top Companies Study - GE Healthcare Life Sciences, …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Bioseparation Systems Market- (By Type (Centrifugation Technology, Cell Disruption Technology, Chromatography Technique, Extraction Technique, Filtration Technologies and Membrane-based Bioseparation and Precipitation), Application (Food, Life Sciences, Pharmaceutical and Biopharmaceutical)), By Region, Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the latest research by InsightAce Analytic, the Global Bioseparation Systems Market is valued at US$
Medical Nutrition Market Key Players Analysis - Abbott Laboratories; Pfizer Inc.; Bayer AG; Nestle S.A.; GlaxoSmithKline plc.
Medical Nutrition Market Key Players Analysis - Abbott Laboratories; Pfizer Inc. …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Global Medical Nutrition Market Size, Share & Trends Analysis Report By Nutrition Type (Proteins, Carbohydrates, Multivitamins & Antioxidants, Amino Acids, Fibers, Minerals), By Indication (Diabetes, Cancer, Gastrointestinal Diseases, Metabolic Syndromes), By Patient Type (Infants, Adults, And Geriatric Populations), Indication (Diabetes, Cancer, Gastrointestinal Diseases, Metabolic Syndromes), End-User (Home Care Settings, Long-Term Care Facilities, And Ambulatory Surgical

All 5 Releases


More Releases for Diabetes

Major Force in the Diabetes Pen Market 2025: Diabetes Fuels Surge In Demand For …
How Will the Diabetes Pen Market Grow, and What Is the Projected Market Size? The diabetes pen market is projected to grow from $29.24 billion in 2024 to $31.22 billion in 2025, at a CAGR of 6.8%. Growth is fueled by the rising need for managing diabetes, advancements in diabetes care, and an increasing focus on patient-friendly medication administration tools. The diabetes pen market is projected to grow strongly, reaching $40.17 billion
Diabetes Monitoring Devices Market: Regaining Its Glory| Ascensia Diabetes Care, …
The Latest Study Published by HTF MI Research on the "Diabetes Monitoring Devices Market'' evaluates market size, trend and forecast to 2029. The Diabetes Monitoring Devices market study includes significant research data and evidences to be a practical resource document for managers and analysts is, industry experts and other key people to have an easily accessible and self-analysed study to help understand market trends, growth drivers, opportunities and upcoming challenges
Prevalence of Diabetes Drives Opportunities for Type-2 Diabetes Market
The Type-2 Diabetes Market Analysis, 2023, by MarkNtel Advisors, presents a well-researched, detail-driven, and accurate study for the stakeholders. This analysis entails prominent aspects like trends, & recent developments, drivers, opportunities, challenges, & restraints, among other parameters, influencing the overall industry expansion across different locations. This report comprises data from historic years (2018-21) & the base year (2022) to put together an estimation of the forecast period (2023-28). According to Type-2 Diabetes Market
Reverse Diabetes with Dr. Merritt’s Diabetes Reversal Recipe
[November 26, 2020] – People suffering from diabetes always search for ways to lower blood sugar levels in their bodies. Diabetes treatment available costs you hundreds of dollars yearly and also restricts you to a diabetic diet. That hampers your mental health and well-being. Apart from this, eye problems, kidney failure, amputations are some of the physical problems diabetic patients face. Dr. Marlene Merritt (from the Merritt Wellness Center in
Diabetes Treatment
Diabetes Treatment is a important way to help manage the healthy ,easy to use and improve the way of the treatment of blood glucose monitoring system. As living standards improve, an increasing obesity, the Diabetes Treatment has improved peoples living habits, disease control effect, is becoming more and more important. The global Diabetes Treatment market is valued at 43700 million US$ in 2018 and will reach 58000 million US$ by the end
Self-Monitoring Blood Glucose Devices Market Study by Advance Application [Type …
The global self-monitoring blood glucose devices market was valued at $7,768 million in 2017 and is projected to reach $10,828 million by 2025 at a CAGR of 4.2% from 2018 to 2025. Monitoring of blood glucose is an essential step in diabetes management. Blood glucose monitoring devices are predominantly used to monitor a patient’s blood glucose level. Self-monitoring blood glucose (SMBG) devices are easy-to-use and enable people to monitor their